What is driving the growth of the global Interventional Radiology Market?

The global interventional radiology market reached an estimated value of around USD 24.20 billion in 2024 and is poised to grow at a robust CAGR of 6.7% between 2025 and 2034, potentially reaching USD 46.29 billion by 2034. This growth is fueled by the rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, coupled with an increasing preference for minimally invasive, image-guided medical procedures which reduce patient recovery times and procedural risks.

Increasing adoption of advanced diagnostic and therapeutic imaging systems, technological innovations integrating artificial intelligence and robotics, expanding healthcare infrastructure in emerging regions, and growing patient awareness about less invasive treatment options are further propelling market expansion.

Overview of the Interventional Radiology Market

Interventional radiology (IR) encompasses a broad range of minimally invasive diagnostic and therapeutic procedures performed under image guidance such as MRI, CT, ultrasound, angiography, and fluoroscopy. These techniques allow physicians to treat conditions involving blood vessels, organs, and other internal structures through small incisions, reducing the need for open surgery.

IR has become instrumental in managing vascular diseases, cancer treatment (through embolization and angioplasty), biopsies, pain management, and other procedures. Its growing adoption has revolutionized modern healthcare by improving outcomes, reducing hospital stays, and decreasing healthcare costs.

Market Segmentation

By Products

MRI Systems: Crucial for soft tissue visualization and guiding biopsies or ablations.

CT Scanners: Widely used for vascular and organ imaging guiding precise interventional procedures.

Ultrasound Imaging Systems: Portable, radiation-free solutions essential for real-time guidance.

Angiography Systems: Key modality for blood vessel imaging in vascular and cardiac interventions.

Biopsy Devices: Tools enabling minimally invasive tissue sampling.

Fluoroscopy Systems: Provide continuous X-ray imaging during interventions.

Others: Include contrast media, radiation therapy equipment, and software systems.

By Technology

Catheters: Central to most IR procedures for navigation and treatment delivery.

Stents: Widely used to maintain vessel patency post-intervention.

Inferior Vena Cava (IVC) Filters: Prevent pulmonary embolisms in at-risk patients.

Hemodynamic Flow Alteration (HFA) Devices: Control blood flow for therapeutic benefit.

Angioplasty Balloons: Used to dilate stenosed blood vessels.

Thrombectomy Systems: Remove blood clots.

Embolization Devices: Used for targeted vessel occlusion in cancer or hemorrhage.

Biopsy Needles: For tissue sampling.

Accessories: Include guide wires, sheaths, and others facilitating interventions.

By Procedure

Angioplasty and Angiography: Largest procedural segments focused on vascular disease management.

Embolization: Critical in oncology for tumor blood supply reduction.

Thrombolysis: Used for clot dissolution in emergency care.

Biopsy and Drainage: Minimally invasive diagnostic sampling and fluid removal.

Vertebroplasty and Nephrostomy: Specialized procedures for spine and kidney respectively.

Other Procedures: Include ablation and other emerging techniques.

By Application

Cardiology: Largest application area due to cardiovascular disease burden.

Urology and Nephrology: Increasing use owing to minimally invasive kidney and urinary tract treatments.

Oncology: Rapidly expanding with embolization and ablation therapies.

Gastroenterology: Growing demand for endoscopic and biliary interventions.

Obstetrics: Including fetal interventions and vascular treatments.

Others: Encompassing neurology, pulmonology, and pain management.

By End User

Hospitals: Primary users with advanced IR suites.

Clinics: Expanding outpatient procedures in specialty clinics.

Ambulatory Surgical Centers: Growing in popularity for lower complexity IR treatments.

Others: Includes diagnostic centers and research institutions.

By Region

North America: The largest market share (~42% in 2024) driven by advanced healthcare infrastructure and high IR adoption rates.

Europe: Mature market with steady growth and strong R&D activities.

Asia Pacific: Fastest growing region powered by expanding healthcare access and rising incidence of chronic diseases.

Latin America and Middle East & Africa: Emerging markets with increasing healthcare investments.

Market Drivers

Growing incidence of chronic diseases necessitating minimally invasive interventions.

Rising demand for image-guided procedures offering reduced procedural risks and hospital stays.

Technological advances in imaging modalities and device innovation, including AI and robotics integration.

Increasing healthcare expenditure and infrastructure development in emerging markets.

Patient awareness pushing demand for less invasive and more personalized treatment.

Expansion of outpatient and ambulatory centers favoring minimally invasive procedures.

Market Trends and Innovations

Rapid adoption of artificial intelligence and machine learning to improve diagnostic and procedural accuracy.

Robotics-assisted interventional radiology enhancing precision and reducing operator fatigue.

Development of miniaturized and flexible catheters improving patient comfort and expanding procedure capability.

Increasing use of contrast-enhanced imaging and fusion imaging for better lesion targeting.

Growth of biopsy and ablation technologies enabling earlier and safer diagnosis and treatment of cancers.

Expansion of telemedicine and remote guidance systems facilitating access in under-resourced areas.

Leading Companies in Interventional Radiology

General Electric

Koninklijke Philips N.V.

Carestream Health

Hitachi, Ltd.

Hologic, Inc.

Shimadzu Corporation

Siemens Healthcare GmbH

Canon Medical Systems Corporation

Samsung Medison Co., Ltd.

Medtronic Plc

Agfa-Gevaert Group

Teleflex Incorporated

Analogic Corporation

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Trivitron Healthcare

Stryker Corporation

Olympus Corporation

Toshiba Medical Systems

These companies actively invest in R&D, mergers & acquisitions, and geographic expansion to capture significant market share.

Explore More Reports

Electronic Health Records (EHR) Market

Implantable Medical Devices Market

Mexico Clinical Trials Market

Allergic Rhinitis Epidemiology Forecast

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com